Related Experiment Videos

NSCLC in the elderly--the legacy of therapeutic neglect

Jared Weiss1, Corey Langer

  • 1Division of Hematology and Oncology, University of Pennsylvania, 3400 Civic center Boulevard, PCAM 2, Philadelphia, PA 19104, USA. Jared.Weiss@uphs.upenn.edu

Current Treatment Options in Oncology
|May 19, 2009
PubMed

Insights

Elderly patients with non-small cell lung cancer (NSCLC) are often excluded from clinical trials. However, evidence suggests fit elderly individuals benefit from standard treatments, while less fit patients may require tailored, less aggressive therapies.

Area of Science:

  • Oncology
  • Geriatric Medicine
  • Clinical Trials

Background:

  • Non-small cell lung cancer (NSCLC) predominantly affects the elderly population.
  • Elderly patients are frequently underrepresented or excluded from clinical trials guiding cancer care.
  • This underrepresentation leads to disparities in treatment for elderly NSCLC patients.

Purpose of the Study:

  • To review the evidence guiding treatment decisions for elderly patients with non-small cell lung cancer.
  • To highlight the underrepresentation of elderly individuals in clinical trials and its implications.
  • To provide recommendations for optimizing care and clinical trial participation for older adults with NSCLC.

Main Methods:

  • Analysis of subgroup data and meta-analyses from large clinical trials involving elderly NSCLC patients.
  • Review of existing literature on treatment efficacy and outcomes in older adults.
  • Consideration of patient-specific factors including performance status and comorbidities.

Main Results:

  • Fit elderly patients with NSCLC appear to benefit equally from standard treatments (surgery, chemoradiation, chemotherapy) as younger patients.
  • Less fit elderly patients, particularly those with poor performance status or comorbidities, may benefit from less aggressive treatment regimens.
  • Treatment decisions should integrate clinical evidence with individual patient characteristics and priorities.

Conclusions:

  • Elderly patients with NSCLC should not be excluded from curative or palliative therapies.
  • Aggressive recruitment of elderly individuals into clinical trials, including those designed for specific subgroups, is crucial.
  • Personalized treatment strategies are essential for optimizing outcomes in the diverse elderly NSCLC population.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare: